Hosted by the American Thoracic Society, the 2025 Respiratory Innovation Summit will unite the innovators, investors, clinicians and advocacy groups who are leading the charge to create powerful new treatments for deadly and crippling diseases of the lungs and airways. This meeting historically attracts 390+ global leaders representing all facets of the respiratory industry, including representatives from start-ups, business development, venture capital, government, academia and clinical medicine.

All companies innovating in pulmonary, critical care or sleep are encouraged to apply. All applications will be reviewed; 80 companies will be selected for poster presentation. Of those, 25 will be also programmed for oral presentation. The agenda also includes venture capital panel, angel investor, panel business development panel, and plenty of time for networking. For questions

REGISTRATION

Your registration includes a networking reception with keynote address on Friday, May 16 as well as a full day of programming, continental breakfast, luncheon, plenty of networking time and a closing reception on Saturday, May 17.

Like our Postgraduate Courses, the Respiratory Innovation Summit registration is in the same system as the ATS 2025 International Conference, either as a single event or an additional fee to your ATS 2025 full registration. Attendance at the Respiratory Innovation Summit does not include OR require full registration for ATS 2025, but attendees are encouraged to be a part of our community. Respiratory Innovation Summit attendees are encouraged to take advantage of the hotel blocks offered during the event.

The Respiratory Innovation Summit (RIS) is a NON-CME program.

• The panels were chosen thoughtfully, and the event was a pleasant mix of patient advocates, FDA and government representatives, and big Pharma leaders. As a small company program lead, this was inspiring and informative on what could be accomplished in pulmonary innovation. Heather Lynn
  Haya Therapeutics
• The RIS2024 event at ATS was a great event for Halo Biosciences - well organized, exceptional communication throughout, and a carefully crafted ecosystem that enabled us to share the latest news about our work in pulmonary hypertension and to engage with stakeholders, both old and new.Anissa Kalinowski
  Halo Biosciences
• "RIS is a great forum to showcase new ideas, shifting paradigms, and cutting-edge technologies, all in the fervent practical pursuit of innovation through partnering and collaborations" A. Rahmo PhD
• "The leadership team at the American Thoracic Society has established an example for other associations on how to engage constructively, ethically and productively with industry. The Respiration Innovation Summit stands as an important product of this collaboration." Sylvain Lanouette
• “It is the best run industry event. No other group brings together players of all sizes to work for a common goal.” Marty Hamlen